Arkolith/Insider Trading/CORT/Form 4

Guyer William

Chief Development OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Mar 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$424K
Net Open-Market Flow
-$424K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2026Option exercise(M)12K$21.65$255K14K
Mar 20, 2026Sell(S)12K$36.01$424K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 20, 2026Option exercise(M)12K—$0210K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-122136) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML